Oral Decitabine–cedazuridine Versus Intravenous Decitabine for Myelodysplastic Syndromes and Chronic Myelomonocytic Leukaemia (ascertain): A Registrational, Randomised, Crossover, Pharmacokinetics, Phase 3 Study
Garcia-Manero, Guillermo; McCloskey, James; Griffiths, Elizabeth A; Yee, Karen W L; Zeidan, Amer M; Al-Kali, Aref; Deeg, H Joachim; Patel, Prapti A; Sabloff, Mitchell; Keating, Mary-Margaret; Zhu, Nancy; Gabrail, Nashat Y; Fazal, Salman; Maly, Joseph; Odenike, Olatoyosi; Kantarjian, Hagop; DeZern, Amy E; O’Connell, Casey L; Roboz, Gail J; Busque, Lambert; Buckstein, Rena; Amin, Harshad; Randhawa, Jasleen; Leber, Brian; Shastri, Aditi; Dao, Kim-Hien; Oganesian, Aram; Hao, Yong; Keer, Harold N; Azab, Mohammad; Savona, Michael R
pdfen2024